Register for free to
view the full innovation profile.
This software has significantly enabled quantization of Meissner Corpuscles by markedly decreasing the time required for assembly of images for Meissner corpuscles analysis.
About
Description: This invention is software that enhances the usability of Lucid Inc. for the purpose of using their Vivascope devices for assessment of Meissner Corpuscle density as a measure of sensory neuropathies. Applications: This software has significantly enabled quantization of Meissner Corpuscles by markedly decreasing the time required for assembly of images for Meissner corpuscles analysis and also by simplifying and semi-automating counts and morphologic and morphometric assessments of Meissner Corpuscles. This software will enable Meissner corpuscle density assessment as a measure of various sensory neuropathies including from HIV infection, diabetes and inherited neuropathies such as Charcot Marie Tooth Neuropathy.